When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Dr. Reddy's Labs ADR now meets that criteria, with a jump from 78 to 81 Wednesday.
Hone Your Stock-Picking Skills By Focusing On These Factors
This unique rating tracks technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the trailing 52 weeks matches up against the rest of the market.
Over 100 years of market history reveals that the best stocks typically have an 80 or higher RS Rating in the early stages of their moves.
Dr. Reddy's Labs ADR is working on a consolidation with a 16.89 entry. See if it can clear the breakout price in heavy trade.
Dr. Reddy's Labs ADR saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 16%. Revenue rose from 13% to 17%.
Dr. Reddy's Labs ADR earns the No. 1 rank among its peers in the Medical-Generic Drugs industry group. ANI Pharmaceuticals and Collegium Pharmaceutical are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
